首页> 外国专利> Bone Morphogenetic Protein-2 And Bone Morphogenetic Protein-4 In The Treatment And Diagnosis Of Cancer

Bone Morphogenetic Protein-2 And Bone Morphogenetic Protein-4 In The Treatment And Diagnosis Of Cancer

机译:骨形态发生蛋白2和骨形态发生蛋白4在癌症的治疗和诊断中的作用

摘要

The present invention pertains to the use of BMP-2 and/or BMP-4 as 1) targets for cancer treatment therapies and 2) means to diagnose cancer. The therapeutic component of this invention involves administering to a patient a composition that inhibits bone morphogenetic protein-2 activity and/or bone morphogenetic protein-4 activity. Such inhibition may be accomplished by ligands or antibodies that bind to BMP-2 and/or BMP-4 or receptors for BMP-2 and BMP-4. It may also be achieved by preventing the processing of pro-BMP-2 and/or pro-BMP-4, or blocking transcription or replication of BMP-2 DNA and/or BMP-4 DNA or translation of BMP-2 mRNA and/or BMP-4 mRNA. The diagnostic component of the invention involves measuring the BMP-2 and/or BMP-4 level(s) in biological samples from both a patient and a non-cancerous subject and comparing those levels. Elevated levels of BMP-2 and/or BMP-4 in the patient compared to the subject indicate cancer.
机译:本发明涉及BMP-2和/或BMP-4作为1)癌症治疗靶标和2)诊断癌症的手段的用途。本发明的治疗成分涉及向患者施用抑制骨形态发生蛋白2活性和/或骨形态发生蛋白4活性的组合物。可以通过与BMP-2和/或BMP-4或BMP-2和BMP-4受体结合的配体或抗体来实现这种抑制。也可以通过阻止pro-BMP-2和/或pro-BMP-4的加工或阻止BMP-2 DNA和/或BMP-4 DNA的转录或复制或BMP-2 mRNA和/或翻译的实现来实现或BMP-4 mRNA。本发明的诊断成分涉及测量来自患者和非癌受试者的生物样品中的BMP-2和/或BMP-4水平,并比较那些水平。与受试者相比,患者中BMP-2和/或BMP-4水平升高表明癌症。

著录项

  • 公开/公告号US2003134790A1

    专利类型

  • 公开/公告日2003-07-17

    原文格式PDF

  • 申请/专利号US20020139814

  • 发明设计人 JOHN LANGENFELD;

    申请日2002-05-02

  • 分类号A61K38/17;A61K38/43;

  • 国家 US

  • 入库时间 2022-08-22 00:10:24

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号